Encapsulation of insulin–cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery

References

• BELMIN, J. and VALENSI, P., 2003, Novel drug delivery systems for insulin. Drugs Aging, 20, 303–312.
   PubMedGoogle Scholar
• BEN-JEBRIA, A., ESKEW, M. L., and EDWARDS, D. A., 2000, Inhalation system for pulmonary aerosol drug delivery in rodents using large porous particles. Aerosol Science and Technology, 21, 421–433.
   Google Scholar
• DOTSIKAS, Y. and LOUKAS, Y., 2002, Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Conformation of complexation with electrospray mass spectrometry and 1H NMR. Journal of Pharmaceutical and Biomedical Analysis, 29, 487–494.
   PubMedGoogle Scholar
• EDWARDS, D. A., HANES, J., CAPONETTI, G., HRKACH, J., BEN-JEBRIA, A., ESKEW, M. L., MINTZES, J., DEAVER, D., LOTAN, N., and LANGER, R., 1997, Large porous particles for pulmonary drug delivery. Science, 276, 1868–1871.
   Google Scholar
• GALE, E. A. M., 2001, Two cheers for inhaled insulin. The Lancet, 357, 324.
   PubMedGoogle Scholar
• HINCHCLIFFE, M. and ILLum, L., 1999, Intranasal insulin delivery and therapy. Advanced Drug Delivery Reviews, 35, 199–234.
   PubMedGoogle Scholar
• HOSNY, E. A., AL-SHORA, H. I., and ELMAZAR, M. A., 2002, Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. International Journal of Pharmaceutics, 237, 71–76.
   Google Scholar
• KAWASHIMA, Y., YAMAMOTO, H., TAKEUCHI, H., FUJIOKA, S., and HINO, T., 1999, Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nano-spheres to prolong hypoglycemic effect. Journal of Controlled Release, 62, 279–287.
   PubMed Web of Science ®Google Scholar
• KOMPELLA, U. B. and LEE, V. H. L., 2001, Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Advanced Drug Delivery Reviews, 46, 211–245.
   PubMedGoogle Scholar
• LANGER, R., 2000, Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Accounts of Chemical Research, 33, 94–101.
   PubMedGoogle Scholar
• Li, Y., So, Z., and MITRA, A. K., 1992, Dissociation of insulin oligomers by bile salt micelles and its effects on a-chymotrypsin-mediated proteolytic degradation. Pharmaceutical Research, 9, 864–869.
   PubMedGoogle Scholar
• Liu, F. Y., SHAO, Z., KILDSIG, D. 0., and MITRA, A. K., 1993, Pulmonary delivery of free and liposomal insulin. Pharmaceutical Research, 10, 228–232.
   Google Scholar
• OKOMURA, K., IWAKAWA, S., TSUGUCHIKA, Y., TOSHIMITSU, S., and KOMADA, F., 1992, Intratracheal delivery of insulin absorption from solution and aerosol by rat lung. International Journal of Pharmaceutics, 88, 63–73.
   Google Scholar
• PATTON, S. J., BUKAR, J., and NAGARAJAN, S., 1999, Inhaled insulin. Advanced Drug Delivery Reviews, 35, 235–247.
   PubMedGoogle Scholar
• SAKR, F. M., 1996, The pharmacokinetics of pulmonary nebulized insulin and its effect on glucose tolerance in streptozocin-induced diabetic rabbits. International Journal of Pharmaceutics, 128, 215–222.
   Google Scholar
• SAUDEK, C. D., 1993, Future developments in insulin delivery systems. Diabetes Care, 16, 122–132.
   PubMedGoogle Scholar
• SCHIPPER, N. G. M., ROMEIJN, S. G., VERHOEF, J. C., and MERKUS, F. W. H., 1993, Nasal insulin delivery with dimethyl-fi-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations. Pharmaceutical Research, 10, 682–686.
   PubMedGoogle Scholar
• SHAO, Z., KRISHNAMOORTHY, R., and MITRA, A. K., 1992, Cyclodextrins as nasal absorp-tion promoters of insulin: mechanistic evaluations. Pharmaceutical Research, 9, 1157–1163.
   PubMedGoogle Scholar
• SHAO, Z., LI, Y., CHERMAK, T., and MITRA, A. K., 1994a, Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of 13-cyclodextrin derivatives on a-chymotryptic degradation and enteral obsorption of insulin in rats. Pharmaceutical Research, 11, 1174–1179.
   PubMedGoogle Scholar
• SHAO, Z., Li, Y., KRISHNAMOORTHY, R., CHERMACK, T., and MITRA, A. K., 1993, Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, alpha-chymotryptic degradation, and enteral absorption of insulin hexamers. Pharmaceutical Research, 10, 243–251.
   PubMedGoogle Scholar
• SHAO, Z., Li, Y., and MITRA, A. K., 1994b, Cyclodextrins as mucosal absorption promoters of insulin. III. Pulmonary route of delivery. European Journal of Pharmaceutics and Biopharmaceutics, 40, 283–288.
   Google Scholar
• SILVA CUNHA, A., CHERON, M., GROSSIORD, J. L., PUISIEUX, F., and SEILLER, M., 1998, W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetics rats. International Journal of Pharmaceutics, 169, 33–44.
   Google Scholar
• SILVA CUNHA, A., GROSSIORD, J. L., PUISIETJX, F., and SEILLER, M., 1997, Insulin in W/O/W multiple emulsions: biological activity after oral administration in normal and diabetics rats. Journal of Microencapsulation, 14, 321–333.
   PubMedGoogle Scholar
• SORIANO, I., EVORA, C., and LLABREs, M., 1996, Preparation and evaluation of insulin-loaded poly(DL-lactide) microspheres using an experimental design. International Journal of Pharmaceutics, 142, 135–142.
   Web of Science ®Google Scholar
• TOKIHIRO, K., IRIE, T., and UEKAMA, K., 1997, Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution. Chemical & Pharmaceutical Bulletin, 45, 525–531.
   PubMedGoogle Scholar
• UCHIDA, T., YAGI, A., ODA, Y., NAKADA, Y., and GOTO, S., 1997, Preparation and characterization of polylactic acid microspheres containing bovine insulin by a W/O/W emulsion solvent evaporation method. Chemical & Pharmaceutical Bulletin, 45, 1539–1543.
   PubMedGoogle Scholar
• WHITE, J. R. and CAMPBELL, R. K., 2001, Inhaled insulin: an overview. Clinical Diabetes, 19, 13–16.
   Google Scholar
• YAMAGUCHI, Y., TAKENAGA, M., KITAGAWA, A., OGAWA, Y., MIZUSHIMA, Y., and IGARASHI, R., 2002, Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. Journal of Controlled Release, 81, 235–249.
   PubMedGoogle Scholar
• ZHANG, Q., SHEN, Z., and NAGAI, T., 2001, Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. International Journal of Pharmaceutics, 218, 75–80.
   PubMedGoogle Scholar